GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shilpa Medicare Ltd (BOM:530549) » Definitions » ROE % Adjusted to Book Value

Shilpa Medicare (BOM:530549) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Shilpa Medicare ROE % Adjusted to Book Value?

Shilpa Medicare's ROE % for the quarter that ended in Dec. 2024 was 5.46%. Shilpa Medicare's PB Ratio for the quarter that ended in Dec. 2024 was N/A. Shilpa Medicare's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was N/A.


Shilpa Medicare ROE % Adjusted to Book Value Historical Data

The historical data trend for Shilpa Medicare's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shilpa Medicare ROE % Adjusted to Book Value Chart

Shilpa Medicare Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.24 5.72 1.95 -1.61 0.80

Shilpa Medicare Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2.45 - 0.90 -

Competitive Comparison of Shilpa Medicare's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Shilpa Medicare's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shilpa Medicare's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shilpa Medicare's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Shilpa Medicare's ROE % Adjusted to Book Value falls into.


;
;

Shilpa Medicare ROE % Adjusted to Book Value Calculation

Shilpa Medicare's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=1.77% / 2.21
=0.80%

Shilpa Medicare's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=5.46% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shilpa Medicare ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Shilpa Medicare's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Shilpa Medicare Business Description

Traded in Other Exchanges
Address
Hyderabad Road, Number 12-6-214/A-1, Shilpa House, Raichur, KA, IND, 584135
Shilpa Medicare Ltd is a specialty and generic drug manufacturer. The company's product range includes over 44 oncology and non-oncology APIs. It uses nano and micro technology in its drug identification and formulation. The operating segments of the company are Pharmaceutical products and services, which is the key revenue-generating segment; and Power sales. Geographically, the group derives revenue from India and Outside India, of which prime revenue is generated from India.

Shilpa Medicare Headlines

No Headlines